Disease control is done with care and support psychological and diets. Several studies have shown that patients with irritable bowel syndrome with gluten-free diet have been well controlled. In contrast, in some studies, the placebo response rate was similar to the gluten free diet. Due to the growing irritable bowel syndrome, gluten unknown effects on the release of gastrointestinal symptoms, this study is a comparative study of a gluten-free diet on gastrointestinal symptoms in patients with irritable bowel syndrome have been implemented.
In a clinical trial conducted during 2012 and 2013 in Tehran's Imam Khomeini Hospital, 72 patients (35 patients in gluten group and 37 patients in placebo group) enter the study. In the first step the patients receive the gluten-free diet for six weeks using a standard visual analog scale (VAS), clinical symptoms include bloating, abdominal pain, satisfaction with stool consistency, nausea, tiredness, patients are asked. At 6 weeks, patients whose symptoms improved to an acceptable level and gluten-free diet is effective in terms of disease, in the second stage are randomly divided into two groups. The first group of packages containing powdered gluten (gluten) and the second group of packages containing powdered food containing gluten (placebo) was given.
At the end of each week , the severity of patients' symptoms are evaluated according to VAS criteria till 6 weeks.